David Fitzgerald


David has over twenty-five years of experience managing private equity, private credit, and venture capital partnerships & investing in high growth companies. David leads Petra’s healthcare investing activities and has spent his entire career focused on the healthcare, information technology and business services sectors.  Prior to joining Petra, David was a General Partner at Richland Ventures, one of the largest venture capital funds in the Southeast. Earlier in his career, David led market development and acquisition activities for InformDx, a diagnostic laboratory company and THG Management Services, a managed healthcare company.

David has board-level experience with many successful growth companies including: SpecialtyCare (sold to American Securities), US Healthworks (sold to Dignity Health), Televox (sold to West Corp.), Appriss (sold to Bain Capital), Synhrgy (sold to Mercer), Salveo Specialty Pharmacy (sold to Catamaran/Optum), New Century Hospice (sold to Curo Health Services/Humana), Clinipace (sold to dMed Global), and CareMetx (sold to General Atlantic).

He currently serves as a director on the boards of Urgent Team, SUN Behavioral Health, Etairos Health, Three Oaks Hospice, Aging With Comfort, Support, Inc., Centerline Healthcare Partners, Acute Behavioral Health, American Vascular Associates, Viva Spa and ABS Kids, where he serves as Chairman.

In the community, David serves as a Trustee on the Board of Harpeth Hall School. David received a B.A. degree from Washington & Lee University.